Charles River Laboratories International (CRL) Total Non-Current Liabilities (2009 - 2025)

Charles River Laboratories International (CRL) has reported Total Non-Current Liabilities for 17 consecutive years, with $3.8 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Total Non-Current Liabilities fell 1.02% year-over-year to $3.8 billion; the TTM figure through Dec 2025 stood at $3.8 billion (down 1.02% YoY), while the FY2025 annual figure was $3.8 billion, down 1.02% from the prior year.
• Total Non-Current Liabilities came in at $3.8 billion for Q4 2025 at Charles River Laboratories International, down from $3.9 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $4.6 billion in Q2 2022, with the low at $3.4 billion in Q1 2021.
• Average Total Non-Current Liabilities over 5 years is $4.1 billion, with a median of $4.2 billion recorded in 2021.
• Across the five-year window, Total Non-Current Liabilities jumped 33.34% in 2021 and declined 11.31% in 2024, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $4.2 billion in 2021, then increased by 5.13% to $4.4 billion in 2022, then decreased by 2.08% to $4.3 billion in 2023, then declined by 11.31% to $3.8 billion in 2024, then fell by 1.02% to $3.8 billion in 2025.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $3.8 billion, $3.9 billion, and $4.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.